What is Argos?
Headquartered in Massachusetts, Argos Corporation operates as a sophisticated manufacturer of custom extrusion tubing, filaments, and high-performance thermoplastics. The firm serves a diverse clientele across the medical, pharmaceutical, and industrial sectors, maintaining rigorous quality standards through its ISO 9001 and ISO 13485 certifications. By focusing on precision engineering and bespoke product development, Argos addresses the complex material requirements of modern healthcare and industrial applications. Their ability to deliver innovative, compliant solutions at scale has established them as a preferred partner for organizations requiring stringent adherence to safety and performance benchmarks in polymer manufacturing.
How much funding has Argos raised?
Argos has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Argos
PPP
Public-Private Partnership
What's next for Argos?
With the recent injection of capital, Argos is well-positioned to accelerate its strategic initiatives, likely focusing on capacity expansion and technological integration to meet the increasing demand for specialized medical-grade materials. The company is expected to prioritize the optimization of its manufacturing footprint, potentially investing in advanced extrusion technologies to enhance production efficiency and product versatility. As the firm navigates the late-stage growth phase, the focus will remain on maintaining its competitive edge through continuous innovation and the expansion of its service offerings to capture a larger share of the global thermoplastic market. This financial milestone provides the necessary liquidity to pursue long-term operational excellence and market leadership.
See full Argos company page
